Monsanto Company (NYSE: MON) is acquiring the activity of crop bioengineering company Rosetta Green Ltd. (TASE: RSTG) for NIS 126 million. Last week, "Globes" revealed that Rosetta Green was in talks over a strategic cooperation agreement with a global seed company. Monsanto decided that a cooperation agreement was not enough, and decided to acquire the company in toto.
Monsanto will apparently pay $35 million for Rosetta Green, plus $2 million in milestone payments. Rosetta Green's share price rose 4.1% on Thursday to NIS 6.54, giving a market cap of NIS 66 million. Monsanto is paying a 90% premium on the market cap.
Monsanto is acquiring Rosetta Green's activity, not the company, which will become a cash-rich stock market shell. Monsanto is best known in Israel for its $35 million investment in crop bioengineering company Evogene Ltd. (TASE:EVGN) and signing a cooperation agreement with it, which could potentially be worth hundreds of millions of dollars to Evogene.
You comment was recieved and soon will be published.
Thank you for posting your comment, which will be reviewed for publication.
Load more comments